Cargando…

Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients

PURPOSE: Temple syndrome (TS14) is a rare imprinting disorder caused by aberrations at the 14q32.2 imprinted region. Here, we report comprehensive molecular and clinical findings in 32 Japanese patients with TS14. METHODS: We performed molecular studies for TS14 in 356 patients with variable phenoty...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagami, Masayo, Nagasaki, Keisuke, Kosaki, Rika, Horikawa, Reiko, Naiki, Yasuhiro, Saitoh, Shinji, Tajima, Toshihiro, Yorifuji, Tohru, Numakura, Chikahiko, Mizuno, Seiji, Nakamura, Akie, Matsubara, Keiko, Fukami, Maki, Ogata, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729347/
https://www.ncbi.nlm.nih.gov/pubmed/28640239
http://dx.doi.org/10.1038/gim.2017.53
_version_ 1783286175286427648
author Kagami, Masayo
Nagasaki, Keisuke
Kosaki, Rika
Horikawa, Reiko
Naiki, Yasuhiro
Saitoh, Shinji
Tajima, Toshihiro
Yorifuji, Tohru
Numakura, Chikahiko
Mizuno, Seiji
Nakamura, Akie
Matsubara, Keiko
Fukami, Maki
Ogata, Tsutomu
author_facet Kagami, Masayo
Nagasaki, Keisuke
Kosaki, Rika
Horikawa, Reiko
Naiki, Yasuhiro
Saitoh, Shinji
Tajima, Toshihiro
Yorifuji, Tohru
Numakura, Chikahiko
Mizuno, Seiji
Nakamura, Akie
Matsubara, Keiko
Fukami, Maki
Ogata, Tsutomu
author_sort Kagami, Masayo
collection PubMed
description PURPOSE: Temple syndrome (TS14) is a rare imprinting disorder caused by aberrations at the 14q32.2 imprinted region. Here, we report comprehensive molecular and clinical findings in 32 Japanese patients with TS14. METHODS: We performed molecular studies for TS14 in 356 patients with variable phenotypes, and clinical studies in all TS14 patients, including 13 previously reported. RESULTS: We identified 19 new patients with TS14, and the total of 32 patients was made up of 23 patients with maternal uniparental disomy (UPD(14)mat), six patients with epimutations, and three patients with microdeletions. Clinical studies revealed both Prader-Willi syndrome (PWS)-like marked hypotonia and Silver-Russell syndrome (SRS)-like phenotype in 50% of patients, PWS-like hypotonia alone in 20% of patients, SRS-like phenotype alone in 20% of patients, and nonsyndromic growth failure in the remaining 10% of patients in infancy, and gonadotropin-dependent precocious puberty in 76% of patients who were pubescent or older. CONCLUSION: These results suggest that TS14 is not only a genetically diagnosed entity but also a clinically recognizable disorder. Genetic testing for TS14 should be considered in patients with growth failure plus both PWS-like hypotonia and SRS-like phenotypes in infancy, and/or precocious puberty, as well as a familial history of Kagami-Ogata syndrome due to maternal microdeletion at 14q32.2.
format Online
Article
Text
id pubmed-5729347
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57293472017-12-15 Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients Kagami, Masayo Nagasaki, Keisuke Kosaki, Rika Horikawa, Reiko Naiki, Yasuhiro Saitoh, Shinji Tajima, Toshihiro Yorifuji, Tohru Numakura, Chikahiko Mizuno, Seiji Nakamura, Akie Matsubara, Keiko Fukami, Maki Ogata, Tsutomu Genet Med Original Research Article PURPOSE: Temple syndrome (TS14) is a rare imprinting disorder caused by aberrations at the 14q32.2 imprinted region. Here, we report comprehensive molecular and clinical findings in 32 Japanese patients with TS14. METHODS: We performed molecular studies for TS14 in 356 patients with variable phenotypes, and clinical studies in all TS14 patients, including 13 previously reported. RESULTS: We identified 19 new patients with TS14, and the total of 32 patients was made up of 23 patients with maternal uniparental disomy (UPD(14)mat), six patients with epimutations, and three patients with microdeletions. Clinical studies revealed both Prader-Willi syndrome (PWS)-like marked hypotonia and Silver-Russell syndrome (SRS)-like phenotype in 50% of patients, PWS-like hypotonia alone in 20% of patients, SRS-like phenotype alone in 20% of patients, and nonsyndromic growth failure in the remaining 10% of patients in infancy, and gonadotropin-dependent precocious puberty in 76% of patients who were pubescent or older. CONCLUSION: These results suggest that TS14 is not only a genetically diagnosed entity but also a clinically recognizable disorder. Genetic testing for TS14 should be considered in patients with growth failure plus both PWS-like hypotonia and SRS-like phenotypes in infancy, and/or precocious puberty, as well as a familial history of Kagami-Ogata syndrome due to maternal microdeletion at 14q32.2. Nature Publishing Group 2017-12 2017-05-31 /pmc/articles/PMC5729347/ /pubmed/28640239 http://dx.doi.org/10.1038/gim.2017.53 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Original Research Article
Kagami, Masayo
Nagasaki, Keisuke
Kosaki, Rika
Horikawa, Reiko
Naiki, Yasuhiro
Saitoh, Shinji
Tajima, Toshihiro
Yorifuji, Tohru
Numakura, Chikahiko
Mizuno, Seiji
Nakamura, Akie
Matsubara, Keiko
Fukami, Maki
Ogata, Tsutomu
Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title_full Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title_fullStr Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title_full_unstemmed Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title_short Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients
title_sort temple syndrome: comprehensive molecular and clinical findings in 32 japanese patients
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729347/
https://www.ncbi.nlm.nih.gov/pubmed/28640239
http://dx.doi.org/10.1038/gim.2017.53
work_keys_str_mv AT kagamimasayo templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT nagasakikeisuke templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT kosakirika templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT horikawareiko templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT naikiyasuhiro templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT saitohshinji templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT tajimatoshihiro templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT yorifujitohru templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT numakurachikahiko templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT mizunoseiji templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT nakamuraakie templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT matsubarakeiko templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT fukamimaki templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients
AT ogatatsutomu templesyndromecomprehensivemolecularandclinicalfindingsin32japanesepatients